These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 2838790)
1. Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes. Yokota J; Wada M; Yoshida T; Noguchi M; Terasaki T; Shimosato Y; Sugimura T; Terada M Oncogene; 1988 Jun; 2(6):607-11. PubMed ID: 2838790 [TBL] [Abstract][Full Text] [Related]
2. Amplification of protooncogenes in surgical specimens of human lung carcinomas. Shiraishi M; Noguchi M; Shimosato Y; Sekiya T Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414 [TBL] [Abstract][Full Text] [Related]
3. Amplification of the N-myc oncogene in an adenocarcinoma of the lung. Saksela K; Bergh J; Nilsson K J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069 [TBL] [Abstract][Full Text] [Related]
4. myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. Johnson BE; Makuch RW; Simmons AD; Gazdar AF; Burch D; Cashell AW Cancer Res; 1988 Sep; 48(18):5163-6. PubMed ID: 2842046 [TBL] [Abstract][Full Text] [Related]
5. Chromosomal deletion, gene amplification, alternative processing, and autocrine growth factor production in the pathogenesis of human lung cancer. Minna JD; Battey JF; Birrer M; Brooks BJ; Cuttitta F; DeGreve J; Gazdar AF; Johnson BE; Nau MM; Sausville EA Princess Takamatsu Symp; 1986; 17():109-22. PubMed ID: 3332004 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas. Gazzeri S; Brambilla E; Chauvin C; Jacrot M; Benabid AL; Brambilla C Cancer Res; 1990 Mar; 50(5):1566-70. PubMed ID: 2154327 [TBL] [Abstract][Full Text] [Related]
7. Expression of the L-myc gene is under positive control by short-lived proteins. Saksela K Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780 [TBL] [Abstract][Full Text] [Related]
8. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. Saksela K; Bergh J; Lehto VP; Nilsson K; Alitalo K Cancer Res; 1985 Apr; 45(4):1823-7. PubMed ID: 2983887 [TBL] [Abstract][Full Text] [Related]
9. Sequence of a germ-line N-myc gene and amplification as a mechanism of activation. Ibson JM; Rabbitts PH Oncogene; 1988 Apr; 2(4):399-402. PubMed ID: 2834684 [TBL] [Abstract][Full Text] [Related]
10. Amplification of oncogenes in lung carcinoma grafted in nude mice. Chauvin C; Jacrot M; Riondel J; Brambilla E; Foote AM; Brambilla C; Benabid AL Anticancer Res; 1989; 9(2):449-52. PubMed ID: 2568771 [TBL] [Abstract][Full Text] [Related]
11. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905 [TBL] [Abstract][Full Text] [Related]
12. Amplification of the int-2 gene in human head and neck squamous cell carcinomas. Somers KD; Cartwright SL; Schechter GL Oncogene; 1990 Jun; 5(6):915-20. PubMed ID: 2193294 [TBL] [Abstract][Full Text] [Related]
13. Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice. Gazzeri S; Brambilla E; Jacrot M; Chauvin C; Benabid AL; Brambilla C Cancer Res; 1991 May; 51(10):2566-71. PubMed ID: 1850659 [TBL] [Abstract][Full Text] [Related]
14. myc family gene abnormality in lung cancers and its relation to xenotransplantability. Gemma A; Nakajima T; Shiraishi M; Noguchi M; Gotoh M; Sekiya T; Niitani H; Shimosato Y Cancer Res; 1988 Nov; 48(21):6025-8. PubMed ID: 3167852 [TBL] [Abstract][Full Text] [Related]
15. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer]. Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200 [TBL] [Abstract][Full Text] [Related]
16. myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer. Johnson BE; Brennan JF; Ihde DC; Gazdar AF J Natl Cancer Inst Monogr; 1992; (13):39-43. PubMed ID: 1327035 [TBL] [Abstract][Full Text] [Related]
17. Rearrangement and co-amplification of L-myc and rlf in primary lung cancer. Mäkelä TP; Shiraishi M; Borrello MG; Sekiya T; Alitalo K Oncogene; 1992 Mar; 7(3):405-9. PubMed ID: 1312699 [TBL] [Abstract][Full Text] [Related]
18. Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. Varley JM; Swallow JE; Brammar WJ; Whittaker JL; Walker RA Oncogene; 1987; 1(4):423-30. PubMed ID: 3330785 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033 [TBL] [Abstract][Full Text] [Related]
20. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]